Technical Analysis for DMTK - DermTech, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -1.71% |
| Alert | Time |
|---|---|
| Outside Day | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/30/2024
DermTech, Inc. Description
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Cancer Melanoma Dermatology Gene Expression Diagnostic Tests Risk Assessment Pathology Biopsy Skin Cancer Assessment Products Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions Non Melanoma Skin Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.8939 |
| 52 Week Low | 0.3 |
| Average Volume | 610,263 |
| 200-Day Moving Average | 1.25 |
| 50-Day Moving Average | 0.58 |
| 20-Day Moving Average | 0.49 |
| 10-Day Moving Average | 0.37 |
| Average True Range | 0.06 |
| RSI (14) | 26.47 |
| ADX | 25.14 |
| +DI | 15.31 |
| -DI | 28.90 |
| Chandelier Exit (Long, 3 ATRs) | 0.49 |
| Chandelier Exit (Short, 3 ATRs) | 0.48 |
| Upper Bollinger Bands | 0.75 |
| Lower Bollinger Band | 0.23 |
| Percent B (%b) | 0.16 |
| BandWidth | 105.15 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.016 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.36 | ||||
| Resistance 3 (R3) | 0.36 | 0.35 | 0.35 | ||
| Resistance 2 (R2) | 0.35 | 0.34 | 0.35 | 0.35 | |
| Resistance 1 (R1) | 0.33 | 0.33 | 0.33 | 0.33 | 0.34 |
| Pivot Point | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Support 1 (S1) | 0.31 | 0.31 | 0.30 | 0.30 | 0.29 |
| Support 2 (S2) | 0.29 | 0.31 | 0.29 | 0.28 | |
| Support 3 (S3) | 0.28 | 0.29 | 0.28 | ||
| Support 4 (S4) | 0.28 |
